Issue: November 2014
October 15, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Trial Scorecard: CHARISMA
Issue: November 2014
Post-hoc analysis of whether beta-blocker use affected CV outcomes in patients without HF but with either prior MI, known atherothrombosis or risk factors alone.
